首页> 外文期刊>Journal of assisted reproduction and genetics >Impact of BRCA1 and BRCA2 mutations on ovarian reserve and fertility preservation outcomes in young women with breast cancer
【24h】

Impact of BRCA1 and BRCA2 mutations on ovarian reserve and fertility preservation outcomes in young women with breast cancer

机译:BRCA1和BRCA2突变对乳腺癌卵巢储备和生育保存结果的影响

获取原文
获取原文并翻译 | 示例
           

摘要

Purpose To determine the impact of BRCA1 and BRCA2 mutations on ovarian reserve and fertility preservation outcome. The main purpose and research question of the study is to determine the impact of BRCA1 and BRCA2 mutations on ovarian reserve and fertility preservation outcomes. Methods Prospective study: 67 breast cancer patients between 18 and 40 years old, undergoing a fertility preservation by means of oocyte storage were considered. Inclusions criteria for the study were age between 18 and 40 years old, BMI between 18 and 28, breast cancer neoplasm stage I and II according to American Joint Committee on Cancer classification (2017) and no metastasis. Exclusion criteria: age over 40 years old, BMI 28, breast cancer neoplasm stage III and IV and do not performed the BRCA test. A total of 21 patients had not performed the test and were excluded. Patients were divided into four groups: Group A was composed by 11 breast cancer patients with BRCA 1 mutations, Group B was composed by 11 breast cancer patients with BRCA 2 mutations, Group C was composed by 24 women with breast cancer without BRCA mutations, and Group D (control) was composed by 181 normal women. Results Group A showed significant lower AMH levels compared to Group C and D (1.2 +/- 1.1 vs 4.5 +/- 4.1 p < 0.05 and 1.2 +/- 1.1 vs 3.8 +/- 2.5 p < 0.05). BRCA1 mutated patients showed a significant lower rate of mature oocytes (MII) compared to Group C (3.1 +/- 2.3 vs 7.2 +/- 4.4 p < 0,05) and Group D (3.1 +/- 2.3 vs 7.3 +/- 3.4; p < 0,05). Breast cancer patients needed a higher dose of gonadotropins compared to controls (Group A 2206 +/- 1392 Group B2047.5 +/- 829.9 Group C 2106 +/- 1336 Group D 1597 +/- 709 p < 0,05). No significant differences were found among the groups considering basal FSH levels, duration of stimulation, number of developed follicles, and number of total retrieved oocytes. Regarding BRCA2 mutation, no effect on fertility was shown in this study. Conclusions The study showed that BRCA1 patients had a higher risk of premature ovarian insufficiency (POI) confirmed by a diminished ovarian reserve and a lower number of mature oocytes suitable for cryopreservation.
机译:目的,以确定BRCA1和BRCA2突变对卵巢储备和生育保存结果的影响。该研究的主要目的和研究问题是确定BRCA1和BRCA2突变对卵巢储备和生育保存结果的影响。方法预期研究:67例乳腺癌患者18至40岁,经过考虑通过卵母细胞储存进行生育保存。该研究的夹杂物标准年龄在18至40岁之间,BMI在18至28岁之间,乳腺癌肿瘤阶段I和II之间,根据美国癌症分类联合委员会(2017年)和没有转移。排除标准:年龄超过40岁,BMI 28,乳腺癌肿瘤阶段III和IV,并且不进行BRCA测试。共有21例患者未进行测试,并被排除在外。患者分为四组:A组是由11名乳腺癌患者组成的BRCA 1突变,B组由11名乳腺癌患者组成BRCA 2突变,C组由24名患有BRCA突变的乳腺癌组成,并且D组(控制)由181名普通女性组成。结果A组A与C组和D相比显示出显着的较低AMH水平(1.2 +/- 1.1 Vs 4.5 +/- 4.1 P <0.05和1.2 +/- 1.1 VS 3.8 +/- 2.5 P <0.05)。与C组(3.1 +/- 2.3 Vs 7.2 +/- 2.3 Vs 7.2 +/- 2.3 Vs 7.2 + / -2.3 Vs 7.3 +/- 3.4; p <0,05)。与对照相比,乳腺癌患者需要更高剂量的促性腺激素(A2206 +/- 1392组B2047.5 +/- 829.9组C 2106 +/-1336组D 1597 +/- 709 P <0.05)。在考虑基础FSH水平,刺激持续时间,发达的卵泡的持续时间和总检索的卵母细胞的数量中没有发现显着差异。关于BRCA2突变,本研究显示了对生育能力的影响。结论该研究表明,BRCA1患者的风险较高,卵巢储备减少,较少数量的成熟卵母细胞,适用于冷冻保存。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号